|
New Genomics Software to Determine Ancestry (About.com)
Computer scientists at Stanford University have developed genomics analysis software that they say appears to be "far more adept than prior methods at unraveling the ancestry of individuals." Known as...
(Apr 9, 2008)
Hepatitis B Virus Triggers Cell 'Suicide' In Patients With Chronic Infection (Science Daily)
Scientists have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so -- that a group of cells important in controlling the disease are triggered to "commit suicide" in patients who are chronically infected. This discovery provides an important new focus for developing therapies or vaccines that boost the body's ability ...
(Apr 9, 2008)
Protein Data Bank Archives 50,000th Molecule Structure (Medical News Today)
The Protein Data Bank (PDB) based at Rutgers, The State University of New Jersey, and the University of California-San Diego (UCSD) this month reached a significant milestone in its 37-year history. The 50,000th molecule structure was released into its archive, joining other structures vital to pharmacology, bioinformatics and education.
(Apr 9, 2008)
Alexandria, Egypt April 9, 2008 (SeedQuest)
Scientists working on barley genome sequencing are aiming to complete it by 2012. Prof Andreas Graner, Acting Director of the Leibniz Institute of Plant Genetics and Crop Plant Research in Germany, said that the International Barley Sequencing Consortium (IBSC) consisting of eight member laboratories in Australia, Japan, Finland, Germany, United Kingdom and the United States is currently working ...
(Apr 9, 2008)
New Jobs Follow New Tenant to North Carolina Research Campus (Business Wire via Yahoo! Finance)
KANNAPOLIS, N.C.----The North Carolina Research Campus announced today at a news conference that PPD, Inc. , a global contract research organization, is opening an office at the campus, which may bring 200 to 300 new jobs.
(Apr 9, 2008)
Pakistani farming 'suffering results of low investment' (SciDev.net)
Pakistan is struggling to reverse the effects of low investment in agricultural research in the 1990s, according to experts.
(Apr 9, 2008)
Hepatitis B virus triggers cell 'suicide' in chronically infected patients (New Kerala)
Washington, Apr 9 : Researches at the University College London have shed light on why some people can fight the Hepatitis B virus (HBV) off successfully while some can't, by finding that a group of cells important in controlling the disease are triggered to 'commit suicide' in patients who are chronically infected.
(Apr 9, 2008)
Deaton Engineering joins Georgetown commercialization center (Austin Business Journal)
Georgetown's Texas Life-sciences Commercialization Center has gained a fourth company, Georgetown-based Deaton Engineering. Deaton is a full-service product engineering firm that works with medical devices, biotechnology and pharmaceutical industries.
(Apr 9, 2008)
PJA Named 2008 Agency of the Year by Advertising Age's BtoB Magazine (Marketwire via Yahoo! Finance)
Following a year of dramatic increase in revenue, several new account wins, an expansion of its services and the development of innovative marketing programs for clients, BtoB Magazine has named PJA Advertising+Marketing as Agency of the Year, according to Mike O'Toole, executive vice president and Partner of the agency.
(Apr 9, 2008)
Protein Data Bank Archives 50,000th Molecule Structure (Newswise)
Worldwide Research Archive doubles in size since 2004.
(Apr 9, 2008)
Business briefs (Everett Herald)
SonoSite, which marks its 10th anniversary as a public company this week, said its first-quarter revenue grew by 22 percent compared with the same period last year.
(Apr 9, 2008)
Hepatitis B Virus Triggers Cell 'Suicide' In Patients With Chronic Infection (Medical News Today)
Scientists from UCL (University College London) have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so - that a group of cells important in controlling the disease are triggered to 'commit suicide' in patients who are chronically infected.
(Apr 9, 2008)
In Storing 1?s and 0?s, the Question Is $ (New York Times)
Digital data degrades over time, and it is unclear how best to preserve it or how much it will cost to do so.
(Apr 9, 2008)
Molecule Delivery Method Improves Stem Cell Differentiation (Newswise)
New research shows that delivering molecules within aggregates of embryonic stem cells via biodegradable microspheres enhances the efficiency and purity of differentiation.
(Apr 9, 2008)
Method to deliver molecules within embryonic stem cells improves differentiation (PhysOrg)
Embryonic stem cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease. However, the inability of stem cells to efficiently develop into the desired specific cell type - such as muscle, skin, blood vessels, bone or neurons - now limits the potential clinical utility of this therapy.
(Apr 9, 2008)
Gene Mutations for Rare Heart Disease Also Found in Kids (HealthDay via Yahoo! News)
WEDNESDAY, April 9 (HealthDay News) -- The same 10 gene mutations responsible for cardiac hypertrophy (thickening of the heart muscle) in adults are also associated with many cases of this rare but life-threatening condition in children, says a U.S. study.
(Apr 9, 2008)
Genetic test offers clues about cardiac hypertrophy in children (EurekAlert!)
Boston, Mass. (April 9, 2008) – A mechanic uses diagnostic tests to determine why your engine is making strange sounds before lifting a wrench to fix the problem.
(Apr 9, 2008)
Gene Mutations for Rare Heart Disease Also Found in Kids (HealthCentral.com)
Copyright © 2008 ScoutNews LLC. All rights reserved.
(Apr 9, 2008)
Hepatitis B virus triggers cell 'suicide' in patients with chronic infection (News-Medical-Net)
Scientists from UCL (University College London) have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so - that a group of cells important in controlling the disease are triggered to 'commit suicide' in patients who are chronically infected.
(Apr 9, 2008)
Invitrogen Teams with MitoSciences to Improve Mitochondrial Disease Research (Centre Daily Times)
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the company will become the exclusive North American distributor of all MitoSciences products, including antibodies and assays used for researching mitochondrial proteins and diseases. MitoSciences currently has the world's largest collection of ...
(Apr 9, 2008)
Signature Genomic Laboratories Introduces Detection Rates Table (Centre Daily Times)
Signature Genomic Laboratories has introduced its updated Detection Rates Table on the company's website. The Detection Rates Table lists, for each of the over 150 genetic disorders tested by Signature's current microarrays, the SignatureChip Whole Genome(TM) (SignatureChipWG(TM)) and SignatureChip Oligo Solution(TM) (SignatureChipOS(TM)), the likelihood that a chromosome abnormality can be ...
(Apr 9, 2008)
University of Delaware (SeedQuest)
Composed of short lengths of ribonucleic acids (RNAs), on the order of about 20 nucleotides long, these novel molecules, called natural antisense microRNAs (nat-miRNAs), target the genes sitting directly across from them on the opposite strand of DNA in a rice cell.
(Apr 10, 2008)
Agilent Technologies Expands miRNA Microarray Catalog with New Human, Mouse and Rat Assays (Centre Daily Times)
Agilent Technologies Inc. (NYSE:A) today introduced three new microRNA microarray designs: Human miRNA Microarray v2.0, Mouse miRNA Microarray v1.0 and Rat miRNA Microarray v1.0. All are based on the Sanger Institute's miRBase 10.1, updated in December 2007.
(Apr 10, 2008)
An Unexpected Way To Cause Leukemia (Science Daily)
Researchers have now used genetic engineering to introduce a mutation found in human leukemia patients into mice. In Cancer Cell they report that the mutation causes leukemia by triggering innate genetic programs that allow white blood cells to proliferate uncontrollably. The findings have implications for the way leukemia should be treated.
(Apr 10, 2008)
Eck gives $20 million to disease center (The Observer)
Notre Dame alumnus Frank Eck has given the University a $20 million gift to support the Center for Global Health and Infectious Diseases (CGHID), which will be renamed the Eck Family Center for Global Health and Infectious Diseases.
(Apr 10, 2008)
Art and science meet on the stage (The Star-Ledger)
Who knew that DNA could be a fashion accessory? Even modern dancers, who shrink from anything that carries a whiff of yesterday, have embraced the swanky appeal of deoxyribonucleic acid, the molecules at the heart of today's most happening controversies over genetic engineering.
(Apr 10, 2008)
$700 million set for upstate revival (Rochester Democrat and Chronicle)
The $121.7 billion 2008-09 state budget approved Wednesday in Albany includes a $700 million Upstate Revitalization Fund.
(Apr 10, 2008)
Takeda to pay $8.8 billion for cancer drugmaker Millennium (Market Watch)
Japan’s Takeda Pharmaceutical says Thursday it’s going to pay $8.8 billion to buy Millennium Pharmaceuticals, a U.S. cancer-drug producer.
(Apr 10, 2008)
New Anti-MMP Antibodies Introduced by AnaSpec AnaSpec Inc. Posted on: 09 Apr 08 (PharmiWeb)
Continuing in its commitment to developing new MMP solutions, AnaSpec has introduced its newest MMP antibodies – anti-MMP-8 (hinge), anti-MMP-9 (hinge), anti-MMP-11 (hinge), anti-MMP-13 (IN) and anti-MMP-28 (IN) antibodies.
(Apr 10, 2008)
10 April 2008 (PharmiWeb)
Dr. Christopher P. Austin, Director of the NIH Chemical Genomics Center will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Austin will present on “Novel Paradigms to Enable Druggability of Genomic and Orphan Disease Targets.”
(Apr 10, 2008)
Celera Grants License to Merck & Co., Inc. for Cancer Targets (Business Wire via Yahoo! Finance)
ALAMEDA, Calif.----Celera , an Applera Corporation business, today announced a two year exclusive license agreement with Merck & Co., Inc. providing Merck with access to up to ten cancer targets for the development of RNA interference- based therapeutics.
(Apr 10, 2008)
Celera Grants License to Merck & Co., Inc. for Cancer Targets (Centre Daily Times)
Celera (NYSE:CRA), an Applera Corporation business, today announced a two year exclusive license agreement with Merck & Co., Inc. providing Merck with access to up to ten cancer targets for the development of RNA interference-(RNAi) based therapeutics. These therapeutic targets are over-expressed on the surface of several different tumor cell types and were identified using Celera's proteomics ...
(Apr 10, 2008)
Japan's Takeda Will Pay $9B for Millennium (TheStreet.com)
The largest overseas acquisition by a Japanese drug maker comes at a 53% premium to Millennium's Wednesday close.
(Apr 10, 2008)
Method To Deliver Molecules Within Embryonic Stem Cells Improves Differentiation (Medical News Today)
Embryonic stem cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease. However, the inability of stem cells to efficiently develop into the desired specific cell type - such as muscle, skin, blood vessels, bone or neurons - now limits the potential clinical utility of this therapy.
(Apr 10, 2008)
Adnavance Technologies Inc. Appoints BioSite Co-Founder Kenneth Buechler, Ph.D., to its Board of Directors (Business Wire via Yahoo! Finance)
VANCOUVER, British Columbia & SAN DIEGO----Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that it has appointed Kenneth Buechler, Ph.D., to its Board of Directors.
(Apr 10, 2008)
CLC bio develops Digital Gene Expression software for developing the potato plant into a super-crop (Press Release Network)
CLC bio, several prominent Danish research institutions, and three crop-enhancing companies have joined forces in a project which aims to develop potatoes into a high-efficient, low-maintenance and multipurpose crop, which cannot only be used for animal and human food, but also for energy and chemical production, like biofuel and starch. The project will make extensive use of Next Generation ...
(Apr 10, 2008)
Takeda Pharmaceutical of Japan to buy Millennium Pharmaceuticals for $8.8 billion (International Herald Tribune)
Takeda said Thursday that it would buy the U.S. company in a friendly cash offer of $25 per share to increase its cancer drug business.
(Apr 10, 2008)
Innovative Drug Discovery Strategies are Critical to the Growth of Pharmaceutical R&D Productivity (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of new Decision Resources report: Navigating the Drug Discovery Landscape: A Strategic Overview of Pharmaceutical R&D to their offering.
(Apr 10, 2008)
Biomarkers may reduce need for biopsies (EurekAlert!)
BOSTON, MA April 10, 2008 – Data presented at this week’s 28th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize transplant patient care.
(Apr 10, 2008)
At New Canaan Library: Ovarian cancer seminar April 17 (New Canaan Advertiser)
“Prove to me I don’t have ovarian cancer.” That’s what one specialist advises all women experiencing the disease’s nonspecific symptoms to demand of their doctors, and of themselves.
(Apr 10, 2008)
Heart And Lung Transplant Patients May No Longer Need Biopsies And Could Receive Personalized Care From Biomarkers (Science Daily)
New data suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize transplant patient care. Non-invasive testing using gene-based blood or urine could offer transplant patients personalized care and medication and may replace the need for costly, invasive biopsy procedures that can be risky for patients. ...
(Apr 10, 2008)
Takeda Pays $8.8 Billion for Biotechnology Firm (New York Times)
The acquisition of Millennium Pharmaceuticals, one of the earliest American genomics companies, by Japan?s largest drug company spurred a rise in biotechnology stocks.
(Apr 10, 2008)
These Stocks Beat Gas Stocks (The Motley Fool)
You may be surprised by the real leaders and laggards.
(Apr 10, 2008)
Gene Mutations for Rare Heart Disease Also Found in Kids (MedicineNet.com)
Title: Gene Mutations for Rare Heart Disease Also Found in Kids Category: Health News Created: 4/10/2008 2:00:00 AM Last Editorial Review: 4/10/2008
(Apr 10, 2008)
Medical Prognosis Institute Selects Insightful Corporation for Predictive Analytics and Reporting (Business Wire via Yahoo! Finance)
SEATTLE----Insightful Corporation , a leading provider of predictive analytics and reporting solutions, announced today that Medical Prognosis Institute , a provider of leading-edge technology based on DNA microarrays, has selected S-PLUS® 8 Enterprise Server, Insightful's software platform for statistical data analysis and predictive analytics.
(Apr 10, 2008)
Stoneville, Mississippi April 10, 2008 (SeedQuest)
A multi-state project to reveal genetic markers for some of the Mid-South’s best rice breeding lines in history is underway with the goal to produce a genetic map of about 470 of the most successful rice varieties.
(Apr 10, 2008)
Scientists develop strategy to rapidly describe outbreak strains with next-generation DNA sequencing (EurekAlert!)
Friday, April 11, 2008 – In the event of an outbreak or a bioterrorist attack, rapid identification of the genetic changes responsible for virulence or drug resistance is essential to mounting an effective response.
(Apr 10, 2008)
Method to deliver molecules within embryonic stem cells improves differentiation (News-Medical-Net)
Embryonic stem cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease.
(Apr 10, 2008)
Molecule delivery method improves stem cell differentiation (News-Medical-Net)
Embryonic stem cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease.
(Apr 11, 2008)
Takeda Pays $8.8 Billion for Biotechnology Firm (NYTimes.com via Yahoo! Finance)
The acquisition of Millennium Pharmaceuticals, one of the earliest American genomics companies, by Japan’s largest drug company spurred a rise in biotechnology stocks.
(Apr 11, 2008)
|
